Online citations, reference lists, and bibliographies.
← Back to Search

Clozapine In The Treatment Of Neuroleptic-induced Blepharospasm: A Report Of 4 Cases.

H. Levin, R. Reddy
Published 2000 · Medicine, Psychology

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Blepharospasm, the forcible closure of eyelids, is an infrequent consequence of neuroleptic treatment that, when severe, can interfere with the ability to walk, drive, or work. Like tardive dyskinesia, blepharospasm can be disfiguring and aesthetically distressing, contributing to the increased stigmatization of patients. CASE REPORTS We report 4 patients with DSM-IV schizoaffective disorder, paranoid schizophrenia, or chronic undifferentiated schizophrenia who developed neuroleptic-induced blepharospasm. In all patients, blepharospasm remitted without the reemergence of psychosis within 3 to 5 months of treatment with clozapine, 100-200 mg/day. CONCLUSION The results suggest that clozapine may successfully treat neuroleptic-induced blepharospasm without the reemergence of psychosis in patients with schizophrenia, schizoaffective disorder, or schizophreniform disorder.



This paper is referenced by
10.1017/s1134066500003969
Blefaroespasmo asociado con olanzapina: un caso clínico
E. Shimizu (2005)
10.1177/0269881103174002
Successful Risperidone Rechallenge after Blepharospasm in a Patient with Schizophrenia: 24-Month Follow-Up
Sanjiv Gulati (2003)
10.1097/YCT.0B013E31806548E4
Electroconvulsive therapy and ocular dystonia.
A. Sharma (2007)
10.1007/978-1-4614-4466-4
Craniofacial Muscles
L. McLoon (2013)
10.1002/mds.10485
Treatment of essential blepharospasm with quetiapine
R. Reeves (2003)
10.1097/01.YCT.0000167464.79327.0D
Remission of tardive dystonia (blepharospasm) after electroconvulsive therapy in a patient with treatment-refractory schizophrenia.
P. Sienaert (2005)
A Case of Amisulpride Induced Tardive Blepharospasm in Schizophrenia
Wu-Ri Park (2012)
10.1097/01.iio.0000167238.26526.a8
Benign Essential Blepharospasm
J. McCann (2005)
10.1097/01.pra.0000327317.34647.28
Transient Tardive Dystonia: Overview and Case Presentation
M. Seeman (2008)
10.1097/WNF.0000000000000106
Are Second-Generation Antipsychotics Useful in Tardive Dystonia?
N. Pinninti (2015)
10.1080/13651500310001077
Meige's syndrome associated with neuroleptic treatment and alcohol abuse
I. Bogdanov (2003)
[Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].
S. Schellini (2006)
10.1097/00004397-200204000-00011
Benign essential blepharospasm.
J. McCann (2002)
10.1016/J.EURPSY.2004.06.010
Blepharospasm associated with olanzapine: a case report.
E. Shimizu (2004)
10.1590/S0004-27492006000100005
Blefarospasmo essencial e espasmo hemifacial: características dos pacientes, tratamento com toxina botulínica A e revisão da literatura
S. Schellini (2006)
10.1007/978-1-4614-4466-4_16
Spastic Facial Muscle Disorders
Juwan Park (2012)
Botulinum Toksinin Blefarospazm ve Hemifasiyal Spazm Tedavisinde Kullanımı
D. Yüksel (2009)
Semantic Scholar Logo Some data provided by SemanticScholar